Patent · US Active

Chemically modified RNA aptamers and uses thereof

US11008576B2 · kind B2 · utility

0Cited by

1References

18Claims

0Family size

Assignee

Albert Einstein College of Medicine · US

Inventors

Matthew Levy · New Rochelle, US
Arijit Bhowmick · Durham, US

Key dates

Filing date	Oct 6, 2017
Grant date	May 18, 2021
Priority date	—
Expiry date	Nov 18, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/51
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are chemically modified ribonucleic acid (RNA) aptamers comprising one or more of 2′F guanylate, 2′OMe cytidylate, 2′OMe adenylate, and a deoxy pyrimidine nucleotide with a moiety on the 5 position of the pyrimidine; and methods of making the aptamers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.